1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Brain Injury Global Clinical Trials Review, H1, 2015

Brain Injury Global Clinical Trials Review, H1, 2015

  • June 2015
  • -
  • Global Data
  • -
  • 87 pages

Brain Injury Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Brain Injury Global Clinical Trials Review, H1, 2015" provides an overview of Brain Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Brain Injury Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Brain Injury 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Brain Injury to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Brain Injury to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Brain Injury 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Brain Injury Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
ZonMw 34
Clinical Trial Overview of ZonMw 34
Novo A/S 35
Clinical Trial Overview of Novo A/S 35
Cato Research Ltd. 36
Clinical Trial Overview of Cato Research Ltd. 36
Canbex Therapeutics Ltd. 37
Clinical Trial Overview of Canbex Therapeutics Ltd. 37
AstraZeneca Plc 38
Clinical Trial Overview of AstraZeneca Plc 38
Astellas Pharma Inc. 39
Clinical Trial Overview of Astellas Pharma Inc. 39
AmKor Pharma, Inc. 40
Clinical Trial Overview of AmKor Pharma, Inc. 40
Alexander David Investments PLC (Inactive) 41
Clinical Trial Overview of Alexander David Investments PLC (Inactive) 41
Actavis Plc 42
Clinical Trial Overview of Actavis Plc 42
Clinical Trial Overview of Top Institutes / Government 43
Vanderbilt University 43
Clinical Trial Overview of Vanderbilt University 43
ALYN Pediatric and Adolescent Rehabilitation Center 44
Clinical Trial Overview of ALYN Pediatric and Adolescent Rehabilitation Center 44
Eunice Kennedy Shriver National Institute of Child Health and Human Development 45
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 45
Shaanxi Provincial People's Hospital 46
Clinical Trial Overview of Shaanxi Provincial People's Hospital 46
Tabriz University of Medical Sciences 47
Clinical Trial Overview of Tabriz University of Medical Sciences 47
University of Nottingham 48
Clinical Trial Overview of University of Nottingham 48
Assistance Publique - Hopitaux de Paris 49
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 49
Associacao de Assistencia a Crianca Deficiente 50
Clinical Trial Overview of Associacao de Assistencia a Crianca Deficiente 50
Atlantic Health System 51
Clinical Trial Overview of Atlantic Health System 51
Baycrest 52
Clinical Trial Overview of Baycrest 52
Five Key Clinical Profiles 53
Appendix 84
Abbreviations 84
Definitions 84
Research Methodology 85
Secondary Research 85
About GlobalData 86
Contact Us 86
Disclaimer 86
Source 87

List of Tables
Brain Injury Therapeutics, Global, Clinical Trials by Region, 2015* 7
Brain Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Brain Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Brain Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Brain Injury Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Brain Injury Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Brain Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Brain Injury Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Brain Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15
Brain Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Brain Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Brain Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18
Brain Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Brain Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Brain Injury Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Brain Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Brain Injury Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Brain Injury Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Brain Injury Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Brain Injury Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Brain Injury Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Brain Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Brain Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Brain Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Brain Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Brain Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 33
Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by ZonMw, 2015* 34
Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2015* 35
Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Cato Research Ltd., 2015* 36
Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Canbex Therapeutics Ltd., 2015* 37
Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 38
Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 39
Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by AmKor Pharma, Inc., 2015* 40
Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexander David Investments PLC (Inactive), 2015* 41
Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis Plc, 2015* 42
Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015* 43
Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by ALYN Pediatric and Adolescent Rehabilitation Center, 2015* 44
Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015* 45
Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Shaanxi Provincial People's Hospital, 2015* 46
Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University of Medical Sciences, 2015* 47
Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nottingham, 2015* 48
Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 49
Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Associacao de Assistencia a Crianca Deficiente, 2015* 50
Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Atlantic Health System, 2015* 51
Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Baycrest, 2015* 52

List of Figures
Brain Injury Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Brain Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Brain Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Brain Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Brain Injury Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Brain Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Brain Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Brain Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15
Brain Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Brain Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Brain Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18
Brain Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Brain Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Brain Injury Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Brain Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Brain Injury Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Brain Injury Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Brain Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Brain Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Brain Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Brain Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Brain Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 85

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.